Inverness and P&G
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble has signed a "non-binding letter of intent" with Inverness Medical Innovations to "form a joint venture to develop and market consumer diagnostic products," the firms announce July 18. The planning required to reach a final agreement will "take several months," they add. The agreement will combine Inverness' experience developing and manufacturing consumer diagnostics with P&G's knowledge of marketing consumer healthcare products, Waltham, Mass.-based Inverness states. Current consumer diagnostic offerings by Inverness include several pregnancy, ovulation and fertility tests under the Clearblue, FactPlus, Accu-Clear, Persona and Clearplan brands...